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Abstract 
OBJECTIVES: The purpose of the current study was to evaluate the effectiveness of 
vapocoolant  for preschoolers’ immunization injection pain relief. 
STUDY DESIGN: 57 4- to 6-year-old children were randomized to vapocoolant alone or typical 
care conditions. Pain was measured at baseline and at injection via self-report, caregiver-report, 
nurse-report, and an observational scale. 
RESULTS: Self-report suggested that children in the vapocoolant alone condition demonstrated 
stronger increases in pain from baseline to injection than typical care. All other measures showed 
significant increases in pain from baseline to injection, but none indicted treatment effects. 
CONCLUSIONS: Consistent with prior studies, vapocoolant might not be an effective pain-
management intervention for children’s intramuscular injections. 
KEY WORDS: Pain control, vapocoolant, immunization, children, pain 
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A Randomized Clinical Trial of Vapocoolant for Pediatric Immunization Pain 
Introduction 
Children exhibit and report high levels of distress during painful medical procedures, 
which can lead to heightened anxiety and pain during subsequent procedures (1, 2). Furthermore, 
early pain has been associated with increased sensitivity to later medical insults (3) and poorer 
future health care attitudes and behaviors (4). Given the potential negative impacts of pediatric 
procedural distress, the development and evaluation of interventions in this area are important 
endeavors. 
Optimal pain management interventions should be effective, safe, and require minimal 
resources (e.g., staff time, cost). One treatment that appears to meet these demands and is 
becoming used regularly in some medical centers is ethyl chloride, often referred to as 
vapocoolant cold spray. Vapocoolant is relatively inexpensive (e.g., approximately $0.50 per 
patient), requires little time to take effect (e.g., approximately 20 seconds), and is easy to use 
(e.g., spray or apply directly to tissue). There is a fair amount of evidence supporting the pain 
management efficacy of vapocoolant for medical procedures in adults (e.g., (5)), but results in 
children have been mixed. For example, two investigations of vapocoolant and placebo spray for 
children revealed no differences between conditions (6, 7). Alternatively, Reis and Holubkov 
(1997) (8) found vapocoolant combined with distraction was superior to distraction alone. 
Unfortunately, this study did not include a vapocoolant alone condition, thus it remains unclear 
whether vapocoolant without distraction is an effective pain management invention for children.  
The purpose of this study was to evaluate the effectiveness of vapocoolant alone for 
pediatric immunization pain. A multi-informant, multi-modal assessment was conducted, which 
employed children’s self-report, caregiver- and nurse-report, and an observational measure of 
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children’s pain. Consistent with Reis and Holubkov, it was hypothesized that children in the 
vapocoolant alone condition would demonstrate lower levels of pain across measures.  
Materials and Methods 
Participants 
  This study was designed in accord with, and adheres to the guidelines detailed in, the 
Consolidated Standards of Reporting Trials (CONSORT) statement (9, 10, 11) (see Figure 1 for 
the CONSORT Flowchart). Appropriate institutional approval was obtained prior to study 
initiation. All participants were recruited from a University-based outpatient primary care clinic. 
Eligible participants were children 4 to 6 years of age receiving routine immunizations in the 
pediatric clinic over a three month period. A power analysis with .80 power and using the large 
effect size of .90 found across a number of measures in a prior study (8) revealed that 15 
participants per condition would be necessary. However, given the null findings in other studies 
(6, 7), it was determined that a larger sample might be appropriate. Thus, approximately 30 
participants per condition were projected. Sixty-nine caregivers were approached to participate in 
this study. The caregivers of 7 children receiving immunizations declined participation. Four of 
these stated that they were not interested and three reported that they did not have enough time to 
participate. Five of the recruited participants were not included in analyses (four did not receive 
injections and one failed to complete the post-immunization ratings). The final sample consisted 
of 57 children and their caregivers. Children were on average about 5 years of age (M = 5.17, SD 
= 0.52). Thirty-two children were female (56%). Thirty-eight children were Caucasian (66.7%), 
six were Asian American (10.5%), three were Native American (5.3%), two were African 
American (3.5%), two were Hispanic (3.5%), and six were reported as Other by their caregiver 
(10.5%). 
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  Caregivers ranged in age from 18 to 56 years (M = 32.92, SD = 8.24), 41 (71.9%) were 
Caucasian, six were Asian American (10.5%), four were Native American (7.0%), three were 
Hispanic (5.3%), one was African American (1.8%), and two reported Other (3.5%). Caregivers’ 
annual income was approximately $42,353.49 (SD = $30,134.77) and they had completed on 
average one year of college education (mean years of education = 13.41, SD = 2.64 years). In 
addition, most caregivers were married (75.4% married, 10.6% separated or divorced, 1.8% 
widowed, 10.5% single, and 1.8% not reported).  
Measures 
Observational instrument. The Child-Adult Medical Procedure Interaction Scale 
(CAMPIS; (12)) served as an observational measure of child injection distress. The subcodes of 
cry, scream, verbal resistance, verbal pain, negative emotion, physical restraint, and flail were 
intercorrelated and combined as a Child Distress composite. 
Research assistants who coded with the CAMPIS were kept blind to study hypotheses 
(e.g., vapocoolant alone hypothesized to be more effective) but not to participant’s group 
assignment given the nature of the intervention utilized. Research assistants were trained 
according to CAMPIS protocol using similar videotaped data from a prior study. A CAMPIS 
code was recorded if it began, occurred, and/or ended at any time during a five-second interval, 
and coding spanned from three minutes prior to cleaning the child’s arm for the immunization 
until the child left the room or three minutes had passed, whichever came first. The codes were 
summed and divided by the total number of five-second intervals in the procedure to obtain a 
percentage score. 
To establish interrater agreement, raters coded the same non-study data until at least 80% 
agreement was found for occurrence of behavior. Once raters reached these criteria, coding of 
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study data began. Twenty percent of the data was randomly selected to check interrater 
agreement with Cohen’s Kappa, a conservative statistic that corrects for chance agreement (13, 
14). Kappa for Child Distress subcodes ranged from .55 (physical restraint) to 1.0 (flail) with the 
average Kappa being .76, which reflects a very good level of agreement (15). 
Child self-report. The Faces Pain Scale-Revised (FPS-R; (16)) was utilized to assess 
children’s self-reported pain at baseline before the immunization and after to assess the pain 
associated with the immunization. The FPS-R consists of six faces exhibiting increasing levels of 
pain intensity. Scores on the FPS-R range from 0 to 10, with 0 representing no pain and 10 
presenting very much pain. The FPS-R has demonstrated adequate reliability and validity (16), 
(17). 
Caregiver- and nurse-report. Prior to the immunization, caregivers and nurses rated child 
baseline distress using a 100mm visual analog scales (VASs) anchored by Not Distressed to 
Very Distressed. Following the immunization, caregivers and nurses used similar VASs to 
indicate child immunization distress. VASs are widely used in pediatric pain studies, they have 
good reliability and validity, and they do not result in the clustering of scores as is common with 
likert-type scales (18, 19). 
Procedure 
Potential participants were approached by a research assistant in the waiting room of the 
pediatric clinic. All pre-procedure measures were completed before the caregivers and 
participants had contact with the medical staff, and before they were assigned to a condition. 
After completing the baseline measures, participants were then randomly assigned to one of two 
conditions (Vapocoolant Alone or Typical Care). A randomization schedule was determined 
before the initiation of data collection and assignments were listed on a form kept in a binder at 
7 
the site. Therefore, the randomization list was not fully concealed from research assistants. After 
a participant was enrolled, researcher assistants assigned conditions based on the next condition 
listed (i.e., Vapocoolant Alone or Typical Care). Thirty-one participants were randomized to 
Vapocoolant Alone condition and 26 to the Typical Care condition. Consistent with the 
procedure of Reis and Holubkov (1997) (8), children assigned to the Vapocoolant Alone 
condition received the vapocoolant solution via the nurse placing a cotton ball saturated with 
vapocoolant on the immunization site for approximately 20 seconds immediately prior to the 
injection. No other intervention was implemented in this condition. Nurses were instructed to 
follow their normal routine. Typical Care involved the usual routine used by nurses in this 
setting. In both conditions, a camcorder in the treatment room was used to record the procedure 
for later behavioral coding. Participants, nurses, and research assistants were not kept blind to 
participant group assignment given the nature of the vapocoolant intervention. 
Results 
Preliminary Analyses 
 Due to technical difficulties with video equipment 3 participants did not have video data 
and therefore could not be evaluated for any observational measures of child distress. These data 
were left as missing points in analyses and other compensatory actions (e.g., inserting a mean 
value) were not taken.   
Preliminary analyses were conducted to determine whether there were any significant 
between-group differences on demographic variables. Chi-square analyses (see Table 1) 
indicated no differences between groups on caregiver and child race and gender. T-tests revealed 
no significant differences between conditions on caregiver educational level, caregiver-report of 
child prior distress during immunizations, and caregiver-report of the amount of pre-procedure 
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child distress (Table 1). Results indicated a significant difference between groups on family 
income with families in the Control group reporting higher incomes than those in the 
Vapocoolant Alone condition, t (41) = 1.95, p = 0.05. Income was not related to any of the 
dependent variables and was thus not used as a covariate in subsequent analyses. 
Treatment Effects 
 Observational. CAMPIS Child Distress composite was analyzed using a repeated 
measures analyses of variance (ANOVA) with one within subjects variable (Time: baseline-
immunization) and one between subjects variable (Group: vapocoolant-control). Results revealed 
a significant main effect for Time, F (1, 53) = 119.86, p < .001, but no significant main effect of 
Group or interaction of Time and Group. 
Caregiver and nurse report. Similar to observational measures, there was a significant 
main effect of time for  caregiver-report, F (1, 54) = 89.10, p < .001, and nurse-report of child 
distress, F (1, 53) = 25.21, p < .001, but no significant main effect of Group or Time x Group 
interaction.  
 Self-report. Analyses involving children’s self-report revealed a significant main effect 
for Time, F (1, 49) = 71.15, p < .001, but no main effect for Treatment on children’s self-report 
(see Table 2). Contrary to observational and report by others findings, children’s self-reported 
distress showed a significant Group x Time interaction,  F (1, 49) = 6.76, p < .05. Follow-up 
analyses indicated that children in the vapocoolant alone group had a more significant increase in 
self-reported pain from baseline to injection than children in the control condition, .  
Discussion 
The purpose of the study was to provide a thorough evaluation of the effectiveness of 
vapocoolant for children’s immunization pain. This evaluation compared vapocoolant alone to 
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typical care. In short, the results do not support vapocoolant alone for reducing children’s 
intramuscular injection pain. This is consistent with prior results (6, 7). The most parsimonious 
explanation is that vapocoolant does not provide effective pain management for children’s 
intramuscular injections. If this is the case, it is important to disseminate the information to avoid 
spending time and money on interventions that are not helpful.  
However, there are other explanations for the lack of treatment effects. It could be that 
the cold sensation after the application of the chemical to the skin was an irritant that offset the 
benefit of any pain relief. This might help explain why children’s self-report reflected heightened 
pain for vapocoolant in this study. Yet, no adverse events were reported to study personnel by 
nurses who administered the vapocoolant. Related, data exist suggesting that children are more 
sensitive to water temperatures than adults (20, 21). Another explanation might be that children 
expected greater pain relief from vapocoolant, and when any pain sensation was experienced, 
children’s anxiety and pain reports were elevated. 
Some discussion of the lack of consistency in results between this study and the one by 
Reis and Holubkov (1997) (8) is in order. First, in the prior study, vapocoolant was not evaluated 
in isolation – it was combined with distraction. There might be some synergistic benefit to this 
combination that resulted in effective anxiety and pain management. It could be that the 
distraction decreased the pain from the cold sensation, which may have eliminated that aversive 
aspect of vapocoolant. 
Another explanation for the lack of findings could be that the sample size did not provide 
sufficient power. Using the effect sizes from the current study, post-hoc analyses revealed that 
sample sizes of 98 (self-report), 212 (observational), 406 (caregiver-report), or 880 (nurse-report) 
would have been needed to find group differences with .80 power. This begs the question as to 
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whether statistical differences in scores with larger samples would truly be clinically meaningful. 
Thus, it is not likely that the results found in this study are the result of Type II error. It could 
also be that the anxiety associated with the injections was sufficiently high which may have 
masked differences in pain scores. Had an anxiety management intervention been employed, 
such as distraction, differences in pain might have been revealed.  
In sum, these results are consistent with those found by Abbot and Fowler-Kerry (1995) 
(6) and Ramsook et al. (2001) (7), and suggest that vapocoolant does not provide effective pain 
management for preschoolers’ immunizations when used alone. Additional evaluations are in 
order, especially for participants of different ages and patients undergoing different procedures. 
In addition, continuing to evaluate vapocoolant paired with additional pain management 
interventions seems warranted.  
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